company background image
DNM

DANAMECO Medical HNX:DNM Stock Report

Last Price

₫25.00k

Market Cap

₫131.3b

7D

-0.4%

1Y

-12.0%

Updated

07 Aug, 2022

Data

Company Financials
DNM fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health4/6
Dividends0/6

DNM Stock Overview

DANAMECO Medical Joint Stock Corporation engages in the manufacture and distribution of medical supplies in Vietnam.

DANAMECO Medical Competitors

Price History & Performance

Summary of all time highs, changes and price drops for DANAMECO Medical
Historical stock prices
Current Share Price₫25,000.00
52 Week High₫63,333.33
52 Week Low₫25,000.00
Beta0.13
1 Month Change-14.68%
3 Month Change-21.47%
1 Year Change-12.02%
3 Year Change248.84%
5 Year Change15.83%
Change since IPO44.23%

Recent News & Updates

Shareholder Returns

DNMVN Medical EquipmentVN Market
7D-0.4%1.2%3.7%
1Y-12.0%-26.1%-7.0%

Return vs Industry: DNM exceeded the VN Medical Equipment industry which returned -26.1% over the past year.

Return vs Market: DNM underperformed the VN Market which returned -7% over the past year.

Price Volatility

Is DNM's price volatile compared to industry and market?
DNM volatility
DNM Average Weekly Movement11.9%
Medical Equipment Industry Average Movement5.9%
Market Average Movement7.4%
10% most volatile stocks in VN Market10.0%
10% least volatile stocks in VN Market4.2%

Stable Share Price: DNM is more volatile than 90% of VN stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: DNM's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of VN stocks.

About the Company

FoundedEmployeesCEOWebsite
1976n/aLi Li Huynhhttps://www.danameco.com

DANAMECO Medical Joint Stock Corporation engages in the manufacture and distribution of medical supplies in Vietnam. The company offers facial products, including procedure, surgical, and medical face masks; respirators; accessories, which include medical caps and shoe covers. It also provides medical gloves; cotton, gauze, and elastic bandage products; medical kits, including gauze kits, FAV kits, delivery, and cotton kits; gowns, such as NON-AAMI disposable, isolation, and surgical gowns; and protective coveralls.

DANAMECO Medical Fundamentals Summary

How do DANAMECO Medical's earnings and revenue compare to its market cap?
DNM fundamental statistics
Market Cap₫131.33b
Earnings (TTM)₫38.99b
Revenue (TTM)₫599.86b

3.4x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
DNM income statement (TTM)
Revenue₫599.86b
Cost of Revenue₫480.59b
Gross Profit₫119.27b
Other Expenses₫80.28b
Earnings₫38.99b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)7.42k
Gross Margin19.88%
Net Profit Margin6.50%
Debt/Equity Ratio149.2%

How did DNM perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is DNM undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DNM?

Other financial metrics that can be useful for relative valuation.

DNM key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.5x
Enterprise Value/EBITDA1.8x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does DNM's PE Ratio compare to its peers?

DNM PE Ratio vs Peers
The above table shows the PE ratio for DNM vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average23.9x
533212 GKB Ophthalmics
30.1xn/a₹383.1m
543309 Adeshwar Meditex
47.3xn/a₹375.2m
MHHL Mohini Health & Hygiene
8.3xn/a₹564.4m
PCYN Procyon
9.7xn/aUS$3.0m
DNM DANAMECO Medical
3.4xn/a₫131.3b

Price-To-Earnings vs Peers: DNM is good value based on its Price-To-Earnings Ratio (3.4x) compared to the peer average (23.9x).


Price to Earnings Ratio vs Industry

How does DNM's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?

Price-To-Earnings vs Industry: DNM is good value based on its Price-To-Earnings Ratio (3.4x) compared to the Asian Medical Equipment industry average (20.8x)


Price to Earnings Ratio vs Fair Ratio

What is DNM's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DNM PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio3.4x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate DNM's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of DNM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: DNM (₫25000) is trading below our estimate of fair value (₫119316.64)

Significantly Below Fair Value: DNM is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is DANAMECO Medical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


16.4%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as DANAMECO Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Examine whether DANAMECO Medical is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.

Past Performance

How has DANAMECO Medical performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


36.2%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: DNM has high quality earnings.

Growing Profit Margin: DNM's current net profit margins (6.5%) are higher than last year (2.1%).


Past Earnings Growth Analysis

Earnings Trend: DNM's earnings have grown significantly by 36.2% per year over the past 5 years.

Accelerating Growth: DNM's earnings growth over the past year (296.8%) exceeds its 5-year average (36.2% per year).

Earnings vs Industry: DNM earnings growth over the past year (296.8%) exceeded the Medical Equipment industry 10.8%.


Return on Equity

High ROE: Whilst DNM's Return on Equity (24.69%) is high, this metric is skewed due to their high level of debt.


Discover strong past performing companies

Financial Health

How is DANAMECO Medical's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: DNM's short term assets (₫360.9B) exceed its short term liabilities (₫251.0B).

Long Term Liabilities: DNM's short term assets (₫360.9B) exceed its long term liabilities (₫90.1B).


Debt to Equity History and Analysis

Debt Level: DNM's net debt to equity ratio (116%) is considered high.

Reducing Debt: DNM's debt to equity ratio has increased from 41.1% to 149.2% over the past 5 years.

Debt Coverage: DNM's debt is well covered by operating cash flow (40.7%).

Interest Coverage: DNM's interest payments on its debt are well covered by EBIT (3.3x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is DANAMECO Medical current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate DNM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate DNM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if DNM's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if DNM's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: DNM is not paying a notable dividend for the VN market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as DNM has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Li Li Huynh

no data

Tenure

Li Li Thi Huynh is CEO & Director of DANAMECO Medical Joint Stock Corporation.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

DANAMECO Medical Joint Stock Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: DANAMECO Medical Joint Stock Corporation
  • Ticker: DNM
  • Exchange: HNX
  • Founded: 1976
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Implied Market Cap: ₫131.328b
  • Shares outstanding: 5.25m
  • Website: https://www.danameco.com

Location

  • DANAMECO Medical Joint Stock Corporation
  • No 12, Trinh Cong Son Street
  • Hoa Cuong Nam Ward
  • Da Nang
  • Vietnam

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/07 00:00
End of Day Share Price2022/08/03 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.